Amanita muscaria is not a single genetic entity — it is a complex of populations that have diverged over millions of years as the species spread across the Northern Hemisphere. Genetic research published in the 2000s revealed that what we call “fly agaric” is actually several cryptic lineages with distinct evolutionary histories, different geographic ranges, […]
GABA — gamma-aminobutyric acid — is the brain’s primary inhibitory neurotransmitter, present in approximately 30–40% of all synaptic connections in the central nervous system. Muscimol, the main active compound in Amanita muscaria, acts directly on GABA-A receptors — the same receptor system targeted by benzodiazepines, barbiturates, and anaesthetic agents. Understanding what GABA does and how […]
Neuroinflammation — chronic or excessive activation of the brain’s immune cells — is increasingly recognised as a factor in neurodegenerative diseases, depression, and cognitive decline. Muscimol, the primary active compound in Amanita muscaria, has been investigated in preclinical research for its potential effects on microglial cells — the brain’s resident immune system. This article summarises […]
Ibotenic acid and muscimol are the two primary active compounds in Amanita muscaria — but they work in completely opposite ways in the brain. Understanding the difference between them is essential to understanding the fly agaric mushroom’s pharmacological profile, why drying matters, and why dried specimens behave differently from fresh ones. This article presents the […]
Neuropathic pain — pain arising from damage or dysfunction in the nervous system rather than from tissue injury — is one of the most difficult pain conditions to treat. Standard analgesics are often ineffective, and current treatments leave many patients with inadequate relief. The GABAergic system plays a documented role in neuropathic pain modulation, and […]
Among the research areas attracting attention in the study of muscimol — the primary active compound in Amanita muscaria — epilepsy stands out as one with a long preclinical history. The GABAergic system is directly implicated in seizure regulation, and muscimol’s action as a direct GABA-A receptor agonist has made it a tool in epilepsy […]
Anxiety and depression are among the most researched areas in contemporary neuropharmacology, and the GABAergic system sits at the centre of both. Muscimol — the primary active compound in Amanita muscaria — acts directly on GABA-A receptors, making it a molecule of genuine scientific interest in this context. This article presents a factual summary of […]
Scientific interest in Amanita muscaria has grown considerably over the past two decades. Once confined to toxicology and mycology, research into the fly agaric mushroom now spans neuropharmacology, sleep science, and ethnobotany. This article brings together the key peer-reviewed studies and what they actually tell us about the compounds found in dried amanita muscaria — […]
Sleep research has become one of the most active frontiers in neuroscience, and muscimol — the primary active compound in Amanita muscaria — has emerged as a molecule of interest due to its direct interaction with the GABA-A receptor system. This article presents a factual overview of the current peer-reviewed research examining muscimol’s relationship to […]
Amanita muscaria and psilocybin mushrooms are both psychoactive fungi — but they are entirely different species, with different active compounds, different mechanisms of action, and different legal statuses. If you are researching fly agaric or considering purchasing dried amanita muscaria powder, understanding this distinction matters. This article presents a factual, science-based comparison. Two Completely Different […]